Generated: December 16, 2017
DrugPatentWatch Database Preview
Details for Patent: 6,652,880
« Back to Dashboard
Which drugs does patent 6,652,880 protect, and when does it expire?
Summary for Patent: 6,652,880
|Title:|| Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants|
|Abstract:||This invention is directed to pharmaceutical compositions for oral administration, wherein the drug or active ingredient is known to have stability problems associated with the use of free fatty acids. The compositions of the invention enhance the solubility of such compounds and improve the storage stability thereof and can be advantageously used in soft-gel and hard-shell capsular formulations. The liquid pharmaceutical compositions, according to the present invention, have a drug dissolved in a liquid vehicle. The liquid vehicle comprising a glyceride of a long chain fatty acid and a lypophilic surfactant having an HLB of less than ten. The composition, according to the invention, is also substantially free of free fatty acids.|
|Inventor(s):|| Aylwin; Elizabeth Anne (Swindon, GB), Banbury; Susan (Cheltenham, GB), Ferdinando; Josephine Joan Christine (Tadley, GB), de Nijs; Henrik (Oss, NL) |
|Assignee:|| R.P. Scherer Technologies, Inc. (Paradise Valley, NV) |
Patent Claim Types:|
see list of patent claims
|Composition; Dosage form; |
Foreign Priority and PCT Information for Patent: 6,652,880
|Foriegn Application Priority Data|
||Foreign Patent Number
||Foreign Patent Date
|United Kingdom||9907715||Apr 01, 1999|
|PCT Filed||March 29, 2000||PCT Application Number:||PCT/US00/08426|
|PCT Publication Date:||October 12, 2000||PCT Publication Number:||
International Patent Family for Patent: 6,652,880
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.